Jordan Richard Gutweiler, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatoblastoma | 2 | 2008 | 90 | 0.380 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2008 | 29 | 0.320 |
Why?
|
| Pulmonary Blastoma | 1 | 2008 | 41 | 0.310 |
Why?
|
| Hospitals, Urban | 1 | 2007 | 500 | 0.250 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2008 | 732 | 0.210 |
Why?
|
| Pleural Neoplasms | 1 | 2008 | 609 | 0.210 |
Why?
|
| Trauma Centers | 1 | 2007 | 937 | 0.190 |
Why?
|
| Neoplasms, Second Primary | 1 | 2008 | 1052 | 0.180 |
Why?
|
| Neuroblastoma | 1 | 2008 | 1250 | 0.180 |
Why?
|
| Hospitals, Pediatric | 1 | 2007 | 1860 | 0.150 |
Why?
|
| Liver Neoplasms | 2 | 2008 | 4320 | 0.130 |
Why?
|
| Wounds and Injuries | 1 | 2007 | 2491 | 0.120 |
Why?
|
| Mesna | 1 | 2008 | 62 | 0.080 |
Why?
|
| Ifosfamide | 1 | 2008 | 232 | 0.080 |
Why?
|
| Splenic Diseases | 1 | 2008 | 90 | 0.070 |
Why?
|
| Etoposide | 1 | 2008 | 634 | 0.070 |
Why?
|
| Melphalan | 1 | 2008 | 420 | 0.070 |
Why?
|
| Immunoglobulin G | 2 | 2008 | 4544 | 0.070 |
Why?
|
| Vincristine | 1 | 2008 | 1036 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2008 | 629 | 0.060 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2008 | 694 | 0.060 |
Why?
|
| Carboplatin | 1 | 2008 | 794 | 0.060 |
Why?
|
| Sigmoid Diseases | 1 | 2006 | 59 | 0.060 |
Why?
|
| Hepatectomy | 1 | 2008 | 557 | 0.060 |
Why?
|
| Intussusception | 1 | 2006 | 115 | 0.060 |
Why?
|
| Financing, Personal | 1 | 2007 | 309 | 0.060 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2008 | 549 | 0.060 |
Why?
|
| Tacrolimus | 1 | 2008 | 733 | 0.060 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2007 | 385 | 0.060 |
Why?
|
| Lipoma | 1 | 2006 | 293 | 0.060 |
Why?
|
| Incidental Findings | 1 | 2008 | 697 | 0.060 |
Why?
|
| Fluorouracil | 1 | 2008 | 1641 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 13380 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2008 | 1784 | 0.050 |
Why?
|
| Cysts | 1 | 2008 | 681 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2008 | 2218 | 0.050 |
Why?
|
| Cisplatin | 1 | 2008 | 1651 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2008 | 9177 | 0.050 |
Why?
|
| Pneumonectomy | 1 | 2008 | 1119 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 2693 | 0.050 |
Why?
|
| Infant | 3 | 2008 | 36192 | 0.040 |
Why?
|
| Gastric Bypass | 1 | 2006 | 818 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2008 | 42230 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 8529 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 2009 | 3029 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2008 | 2035 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2008 | 2330 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2007 | 2775 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2007 | 2498 | 0.030 |
Why?
|
| Boston | 1 | 2007 | 9326 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 2538 | 0.030 |
Why?
|
| Medicaid | 1 | 2007 | 2818 | 0.030 |
Why?
|
| Length of Stay | 1 | 2007 | 6425 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 2567 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2009 | 5671 | 0.020 |
Why?
|
| Chimerism | 1 | 2009 | 155 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 20570 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 11742 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2007 | 7879 | 0.020 |
Why?
|
| Hospitalization | 1 | 2007 | 10723 | 0.020 |
Why?
|
| Splenectomy | 1 | 2008 | 391 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 17904 | 0.020 |
Why?
|
| Child | 3 | 2008 | 80153 | 0.020 |
Why?
|
| Adolescent | 3 | 2008 | 88319 | 0.020 |
Why?
|
| Male | 5 | 2008 | 360804 | 0.010 |
Why?
|
| Humans | 7 | 2008 | 761504 | 0.010 |
Why?
|
| Probability | 1 | 2008 | 2477 | 0.010 |
Why?
|
| Colectomy | 1 | 2006 | 688 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4853 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 6814 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6484 | 0.010 |
Why?
|
| Graft Survival | 1 | 2008 | 3819 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 2006 | 1161 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 1230 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2008 | 23995 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2008 | 39106 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10766 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 8465 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2008 | 10090 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2008 | 4445 | 0.010 |
Why?
|
| Obesity, Morbid | 1 | 2006 | 1277 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14666 | 0.010 |
Why?
|
| Registries | 1 | 2008 | 8224 | 0.010 |
Why?
|
| Female | 5 | 2009 | 392644 | 0.010 |
Why?
|
| Comorbidity | 1 | 2006 | 10508 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 22169 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 12974 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18252 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2008 | 80636 | 0.010 |
Why?
|
| Pregnancy | 1 | 2009 | 29874 | 0.000 |
Why?
|
| Time Factors | 1 | 2008 | 39967 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2008 | 15631 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2008 | 41487 | 0.000 |
Why?
|
| Mice | 1 | 2009 | 81525 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2008 | 64680 | 0.000 |
Why?
|
| Risk Factors | 1 | 2006 | 74206 | 0.000 |
Why?
|
| Animals | 1 | 2009 | 168459 | 0.000 |
Why?
|
| Middle Aged | 1 | 2006 | 220895 | 0.000 |
Why?
|
| Adult | 1 | 2006 | 221177 | 0.000 |
Why?
|